The data are based on a survey conducted in 2016. It describes the personalized medicine program primary focuses of North American and European healthcare organizations in 2016 and 2018. Some 45% of respondents stated that the primary focus of their organization's personalized medicine program is diabetes, as of 2016. However, 63% expected that this will be the focus in two years time.
Diabetes | 45 | 63 |
Common cancers | 38 | 44 |
Neurological diseases | 33 | 58 |
Cardiovascular | 28 | 39 |
Aging | 24 | 47 |
Autoimmune diseases | 20 | 38 |
Rare or orphan cancers | 12 | 29 |
Other orphan diseases | 8 | 16 |